These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15657376)

  • 41. Differential response of serum LH in hypogonadotropic hypogonadism and delayed puberty to LH-RH stimulation before and after clomiphene citrate administration.
    Snoep MC; de Lange WE; Sluiter WJ; Doorenbos H
    J Clin Endocrinol Metab; 1977 Mar; 44(3):603-6. PubMed ID: 320225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Searching for hereditary hemochromatosis.
    Laudicina RJ
    Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of basal and provocative serum prolactin in differentiating idiopathic hypogonadotropic hypogonadism and constitutional delayed puberty--a diagnostic dilemma.
    Ali L; Adeel A
    J Ayub Med Coll Abbottabad; 2012; 24(2):73-6. PubMed ID: 24397058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.
    Smith R; Donald RA; Espiner EA; Stronach SG; Edwards IA
    J Clin Endocrinol Metab; 1979 Jan; 48(1):167-70. PubMed ID: 106067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: bio- and immunoactive gonadotropins.
    Spratt DI; Bigos ST; Beitins I; Cox P; Longcope C; Orav J
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1562-70. PubMed ID: 1464665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and influence of diagnostic criteria in the assessment of hypogonadism in intrathecal opioid therapy patients.
    Duarte RV; Raphael JH; Labib M; Southall JL; Ashford RL
    Pain Physician; 2013 Jan; 16(1):9-14. PubMed ID: 23340538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypogonadotropic hypogonadism: hormonal responses to low dose pulsatile administration of gonadotropin-releasing hormone.
    Valk TW; Corley KP; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1980 Oct; 51(4):730-8. PubMed ID: 6774991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Value of gonadotropin-releasing hormone testing in the differential diagnosis of androgen deficiency in elderly men.
    Christ-Crain M; Meier C; Huber PR; Zimmerli L; Mueller B
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1280-6. PubMed ID: 15598695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of blindness on plasma luteinizing hormone, follicle-stimulating hormone, prolactin, and testosterone levels in prepubertal boys.
    Bellastella A; Criscuolo T; Sinisi AA; Iorio S; Mazzuca A; Parlato F; Perrone L; Faggiano M
    J Clin Endocrinol Metab; 1987 Apr; 64(4):862-4. PubMed ID: 3102549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy.
    Gomes AR; Souteiro P; Silva CG; Sousa-Pinto B; Almeida F; Sarmento A; Carvalho D; Freitas P
    BMC Infect Dis; 2016 Nov; 16(1):628. PubMed ID: 27809804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful treatment of erectile dysfunction and infertility by venesection in a patient with primary haemochromatosis.
    Hamer OW; Gnad M; Schölmerich J; Palitzsch KD
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):985-8. PubMed ID: 11507369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism.
    Cazzola M; Ascari E; Barosi G; Claudiani G; Daccó M; Kaltwasser JP; Panaiotopoulos N; Schalk KP; Werner EE
    Hum Genet; 1983; 65(2):149-54. PubMed ID: 6418636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypogonadism and associated factors among male Leprosy patients.
    Urgie NT; Surur MO; Nigussie S; Worku Yigazu B; Bobosha K; Aragaw A; Shibru G
    PLoS Negl Trop Dis; 2024 Aug; 18(8):e0012374. PubMed ID: 39102424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypogonadotropic Hypogonadism in Non-Functioning Pituitary Adenomas: Impact of Intervention.
    Monteiro DM; Freitas P; Vieira R; Carvalho D
    Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):368-376. PubMed ID: 28201827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. All that is hypogonadal in haemochromatosis is not due to iron deposition.
    O'Sullivan EP; McDermott JH; Howel Walsh C
    Ir J Med Sci; 2007 Mar; 176(1):45-7. PubMed ID: 17849524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endocrine dysfunction in hereditary hemochromatosis.
    Pelusi C; Gasparini DI; Bianchi N; Pasquali R
    J Endocrinol Invest; 2016 Aug; 39(8):837-47. PubMed ID: 26951056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women.
    Fraser LA; Morrison D; Morley-Forster P; Paul TL; Tokmakejian S; Larry Nicholson R; Bureau Y; Friedman TC; Van Uum SH
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):38-43. PubMed ID: 18523930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetic ketoacidosis and hypogonadotropic hypogonadism in association with transfusional hemochromatosis in a man with beta-thalassemia major.
    Lu JY; Chang CC; Tsai HC; Lin KS; Tsang YM; Huang KM
    J Formos Med Assoc; 2001 Jul; 100(7):492-6. PubMed ID: 11579617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypogonadotropic hypogonadism in men with hereditary hemochromatosis.
    El Osta R; Grandpre N; Monnin N; Hubert J; Koscinski I
    Basic Clin Androl; 2017; 27():13. PubMed ID: 28694969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Endocrine complications of genetic hemochromatosis].
    Paris I; Hermans M; Buysschaert M
    Acta Clin Belg; 1999 Dec; 54(6):334-45. PubMed ID: 10686706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.